ABSTRACT
Introduction: as the coronavirus disease 2019 (COVID-19) vaccines are distributed and administered globally, hesitancy towards the vaccine hinders the immunisation of a significant number of vulnerable populations, such as people living with HIV/AIDS. Hence, this study aims to assess COVID-19 vaccine hesitancy among people living with HIV/AIDS (PLHIV) attending clinical-outpatient follow-up at State Specialist Hospital Maiduguri (SSHM), Borno State, Nigeria. Methods: a hospital-based cross-sectional study design was conducted to assess COVID-19 vaccine hesitancy among 344 PLHIV receiving antiretroviral therapy (ART) at the United States President´s Emergency Plan for AIDS (PEPFAR) clinic in SSHM from 4th January to 25th February 2022. Data were collected using a structured and pretested interviewer-administered questionnaire. The results were presented using frequencies and percentages. The factors that are associated with COVID-19 vaccine hesitancy were identified using the Chi-square statistical test. Results: among the 344 respondents of the study, only 88 (26.6%) received the COVID-19 vaccine. Out of the 256 respondents that did not receive the vaccine, only 10.5% (27/256) are willing to be vaccinated, while the majority;57.8% (148/256) are not willing to be vaccinated and 31.7% (81/256) of the respondents are uncertain, thus resulting in a hesitation rate of 89.45%. There was no statistically significant association between COVID-19 vaccine hesitancy and the study´s independent variables;where p-value is greater than 0.05. Conclusion: hesitancy towards COVID-19 vaccine is high among PLHIV and there is no any statistically significant association between COVID-19 vaccine hesitancy and the independent variables of the study where p-value is greater than 0.05. Hence, it is necessary to develop targeted strategies to boost vaccine uptake among this vulnerable population. © Muktar Musa Shallangwa et al.
ABSTRACT
Introduction: in order to control and prevent the spread of COVID-19, people must have adequate knowledge, a positive attitude, and practice basic preventive procedures towards the disease. This study aims to determine the KAP towards COVID-19 among PLHIV undergoing clinical-outpatient follow-up at SSHM. Methods: a hospital-based cross-sectional study was conducted to determine knowledge, attitude and practice (KAP) towards COVID-19 among 344 participants, who were selected using a simple random sampling technique from 4th January to 25th February 2022. A pretested and structured interviewer-administered questionnaire was used for data collection. Results were summarized in frequencies and percentages. The Chi-square test was used to determine factors influencing KAP. Results: among the 344 participants that were enrolled in the study, adequate knowledge and positive attitude scores (≥75 correct answers) towards COVID-19 were reported in 72.4% and 62.5% of the participants, respectively. Most of the respondents (82%) were not practicing basic preventive procedures against COVID-19. Knowledge and attitude scores were significantly associated (p<0.05) with gender, age, marital status and educational status, while practice score was significantly associated (p<0.05) with gender, marital status, educational status, employment status and time since HIV diagnosis. There was a moderate positive correlation (r=0.60) between knowledge and attitude scores, while there was a low positive correlation (r=0.23) between knowledge and practice scores and attitude and practice scores, respectively. Conclusion: people living with HIV have adequate knowledge, a positive attitude and poor practice towards COVID-19. Therefore, in order to mitigate coronavirus infection among People Living with HIV/AIDS (PLHIV), health talks at ART service delivery points should incorporate information on COVID-19 preventative strategies. © Muktar Musa Shallangwa et al.